These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1498913)

  • 1. Impact of affective illness on gene expression: implications for early and long-term prophylaxis.
    Post RM
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():452A-453A. PubMed ID: 1498913
    [No Abstract]   [Full Text] [Related]  

  • 2. Autosomal recessive inheritance of affective disorders in families of responders to lithium prophylaxis?
    Alda M; Grof E; Cavazzoni P; Duffy A; Martin R; Ravindran L; Grof P
    J Affect Disord; 1997 Jul; 44(2-3):153-7. PubMed ID: 9241575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further evidence for a possible association between serotonin transporter gene and lithium prophylaxis in mood disorders.
    Serretti A; Malitas PN; Mandelli L; Lorenzi C; Ploia C; Alevizos B; Nikolaou C; Boufidou F; Christodoulou GN; Smeraldi E
    Pharmacogenomics J; 2004; 4(4):267-73. PubMed ID: 15111989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological factors in affective disorders and their relevance to lithium prophylaxis.
    Mendlewicz J
    Pharmacopsychiatria; 1982 Jan; 15(1):11-8. PubMed ID: 7063525
    [No Abstract]   [Full Text] [Related]  

  • 5. Prophylactic lithium treatment: treatment response, and patient attitudes toward illness and treatment.
    Schmidt S; Ludwig W; Seibold S; Greil W
    Pharmacopsychiatry; 1988 Nov; 21(6):274-5. PubMed ID: 3244750
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of lithium in South-west Scotland. II. A longitudinal study.
    Morrison DP; McCreadie RG
    Br J Psychiatry; 1985 Jan; 146():74-7. PubMed ID: 3978346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of lithium prophylaxis: a prospective follow-up of affective disorder patients assigned to high and low serum lithium levels.
    Vestergaard P; Licht RW; Brodersen A; Rasmussen NA; Christensen H; Arngrim T; Grønvall B; Kristensen E; Poulstrup I
    Acta Psychiatr Scand; 1998 Oct; 98(4):310-5. PubMed ID: 9821453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of lithium in the affective disorders.
    Johnson G
    Aust N Z J Psychiatry; 1996 Dec; 30(6):715-9. PubMed ID: 9034459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mood disorders: pharmacologic prevention of recurrences. A National Institutes of Health consensus report synopsis.
    Hull RH
    Indiana Med; 1985 Jan; 78(1):36-7. PubMed ID: 3968418
    [No Abstract]   [Full Text] [Related]  

  • 10. Lithium-responsive affective disorders: no association with the tyrosine hydroxylase gene.
    Cavazzoni P; Alda M; Turecki G; Rouleau G; Grof E; Martin R; Duffy A; Grof P
    Psychiatry Res; 1996 Sep; 64(2):91-6. PubMed ID: 8912950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affective disorders & "chemical dependence": lithium for alcohol and drug addiction? A clinical note.
    Flemenbaum A
    Dis Nerv Syst; 1974 Jun; 35(6):281-5. PubMed ID: 17894301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How effective is long-term lithium prophylaxis?
    Vestergaard P
    Acta Psychiatr Scand; 2000 May; 101(5):341-2. PubMed ID: 10823291
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mechanism and clinical effects of drugs for mood disorder].
    Nakagawa S; Koyama T
    Ryoikibetsu Shokogun Shirizu; 2003; (38):358-61. PubMed ID: 12877002
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants.
    Chen G; Hasanat KA; Bebchuk JM; Moore GJ; Glitz D; Manji HK
    Psychosom Med; 1999; 61(5):599-617. PubMed ID: 10511011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotherapies and somatic therapies in affective disorders.
    Klerman GL
    Psychiatr Clin North Am; 1983 Mar; 6(1):85-103. PubMed ID: 6889177
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between prophylactic effect of lithium therapy and family history of affective disorders.
    Engström C; Aström M; Nordqvist-Karlsson B; Adolfsson R; Nylander PO
    Biol Psychiatry; 1997 Sep; 42(6):425-33. PubMed ID: 9285078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How should findings on antisuicidal effects of lithium be integrated into practical treatment decisions?
    Müller-Oerlinghausen B
    Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):126-31. PubMed ID: 12904976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic factors and treatment of mood disorders.
    Alda M
    Bipolar Disord; 2001 Dec; 3(6):318-24. PubMed ID: 11843781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term therapy of affective disorders: monotherapy or polypharmacy?
    König W; Rissom R; Kalfoglu G; Stein A; Reimer F
    Pharmacopsychiatry; 1988 Nov; 21(6):272-3. PubMed ID: 3244749
    [No Abstract]   [Full Text] [Related]  

  • 20. Is there a loss of efficacy of lithium in patients treated for over 20 years?
    Berghöfer A; Müller-Oerlinghausen B
    Neuropsychobiology; 2000; 42 Suppl 1():46-9. PubMed ID: 11093072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.